Whitley Hatton
Publications by Year
Research Areas
Prostate Cancer Treatment and Research, BRCA gene mutations in cancer, Cancer Genomics and Diagnostics, Genetic factors in colorectal cancer, Cancer Immunotherapy and Biomarkers
Most-Cited Works
- → Clinical activity of pembrolizumab in metastatic prostate cancer with microsatellite instability high (MSI-H) detected by circulating tumor DNA(2020)119 cited
- → Comparison of germline mutations in African American and Caucasian men with metastatic prostate cancer(2021)46 cited
- → Outcomes With First-Line PD-1/PD-L1 Inhibitor Monotherapy for Metastatic Renal Cell Carcinoma (mRCC): A Multi-Institutional Cohort(2020)15 cited
- → Family history and pathogenic/likely pathogenic germline variants in prostate cancer patients(2021)9 cited
- → Comparison of germline mutations in African American and Caucasian men with metastatic prostate cancer.(2020)8 cited
- → First-line PD-1/PD-L1 inhibitor monotherapy for advanced renal cell carcinoma (aRCC): A multi-institutional cohort.(2020)4 cited
- → Outcomes of a universal germline screening program in a community urology practice(2024)1 cited
- → Comparison of Caucasian and African-American DNA repair alterations in men with metastatic prostate cancer.(2020)1 cited
- → Royal Academy of Medicine in Ireland Section of Biomedical Sciences(1997)1 cited
- → MP54-12 IMPLEMENTATION AND OUTCOMES OF A UNIVERSAL GERMLINE SCREENING PROGRAM IN A COMMUNITY UROLOGY PRACTICE(2023)